Close Menu

A Coherent Call

In a New York Times op-ed James Watson makes a plea for restarting the "War on Cancer" — he says that "any claim that we are still 'at war' elicits painful sarcasm." He goes on to note that new vigor for the initiative should come from the top, as the US president is the one to pick the NCI head. Watson hopes that person provides strong leadership as well as experience in developing new pharmaceuticals.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.